Related references
Note: Only part of the references are listed.Therapies Aimed at the Gut Microbiota and Inflammation: Antibiotics, Prebiotics, Probiotics, Synbiotics, Anti-inflammatory Therapies
Eamonn M. M. Quigley
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2011)
The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review
P. Moayyedi et al.
GUT (2010)
Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives
Anne Salonen et al.
MICROBIOLOGY-SGM (2010)
Long-term impact of irritable bowel syndrome: a qualitative study
Rebecca Farndale et al.
Primary Health Care Research and Development (2010)
Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN-173 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation
A. Agrawal et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome
Nourieh Hoveyda et al.
BMC GASTROENTEROLOGY (2009)
Fermented milk containing Bifidobacterium lactis DN-173 010 improves gastrointestinal well-being and digestive symptoms in women reporting minor digestive symptoms: a randomised, double-blind, parallel, controlled study
Denis Guyonnet et al.
BRITISH JOURNAL OF NUTRITION (2009)
Treatments for irritable bowel syndrome: patients' attitudes and acceptability
Lynsey R. Harris et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2008)
Evaluation of the Birmingham IBS symptom questionnaire
Andrea K. Roalfe et al.
BMC GASTROENTEROLOGY (2008)
Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care:: a multicentre, randomized, double-blind, controlled trial
D. Guyonnet et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Probiotics and irritable bowel syndrome: a rationale for their use and an assessment of the evidence to date
E. M. M. Quigley et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2007)
Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome
Peter J. Whorwell et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Functional findings in irritable bowel syndrome
Iris Posserud et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Personal view: adequate relief as a primary endpoint in irritable bowel syndrome
AW Mangel
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Design of treatment trials for functional gastrointestinal disorders
E. Jan Irvine et al.
GASTROENTEROLOGY (2006)
Probiotics and irritable bowel syndrome: Rationale, putative mechanisms, and evidence of clinical efficacy
M Camilleri
JOURNAL OF CLINICAL GASTROENTEROLOGY (2006)
The use of probiotics in functional bowel disease
EMM Quigley
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2005)
Probiotics used in human studies
DC Montrose et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2005)
Probiotics as therapeutic agents in irritable bowel syndrome
HJ Krammer et al.
ZEITSCHRIFT FUR GASTROENTEROLOGIE (2005)
Use of diet and probiotic therapy in the irritable bowel syndrome - Analysis of the literature
MH Floch
JOURNAL OF CLINICAL GASTROENTEROLOGY (2005)
Are probiotics useful in irritable bowel syndrome?
SM Faber
JOURNAL OF CLINICAL GASTROENTEROLOGY (2003)
The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40 000 subjects
APS Hungin et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
A review of the role of the gut microflora in irritable bowel syndrome and the effects of probiotics
JAJ Madden et al.
BRITISH JOURNAL OF NUTRITION (2002)
Bifidobacterium animalis strain DN-173 010 shortens the colonic transit time in healthy women: a double-blind, randomized, controlled study
P Marteau et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
Irritable bowel syndrome in general practice: prevalence, characteristics, and referral
WG Thompson et al.
GUT (2000)
Share Paper
